Workflow
神奇制药(600613) - 2024 Q1 - 季度财报
ShenqiShenqi(SH:600613)2024-04-30 09:05

Financial Performance - The company's operating revenue for Q1 2024 was CNY 574,528,830.84, representing a decrease of 1.42% compared to the same period last year[7] - Net profit attributable to shareholders was CNY 23,944,713.73, an increase of 0.65% year-on-year[7] - Operating profit for Q1 2024 was CNY 31,746,214.60, a decrease of 3.1% compared to CNY 32,746,831.05 in Q1 2023[22] - The net profit for Q1 2024 was CNY 25,123,136.63, an increase of 7.57% compared to CNY 23,351,102.30 in Q1 2023[23] - The company reported a total comprehensive income of CNY 25,346,836.31 for Q1 2024, compared to CNY 25,338,281.91 in Q1 2023[23] Cash Flow - The net cash flow from operating activities increased significantly by 82.28%, amounting to CNY 42,806,771.33, due to improved collection of receivables and better expense management[7] - The net cash flow from operating activities increased to CNY 42,806,771.33, compared to CNY 23,483,555.88 in Q1 2023, representing an increase of 82.5%[24] - The net cash flow from financing activities improved to CNY 1,092,398.13, compared to a negative CNY 8,231,985.32 in Q1 2023[25] - The cash outflow from investing activities was CNY 2,250,231.46, a decrease from CNY 23,583,667.45 in the previous year[25] Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,292,343,075.29, reflecting a slight increase of 0.40% from the end of the previous year[7] - Total assets as of March 31, 2024, were CNY 3,292,343,075.29, slightly up from CNY 3,279,335,678.82 at the end of 2023[18] - Total liabilities decreased to CNY 876,639,733.31 from CNY 888,769,635.45 at the end of 2023, a reduction of 1.0%[18] - The company's retained earnings increased to CNY 762,654,723.15, up from CNY 738,919,547.12 at the end of 2023, reflecting a growth of 3.2%[18] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 61,918[12] - The largest shareholder, Guizhou Magic Holdings, held 22.59% of the shares, with 120,661,620 shares pledged[12] Research and Development - The company reported a decrease in research and development expenses by 53.24%, primarily due to reduced investment in manufacturing R&D during the reporting period[9] - Research and development expenses for Q1 2024 were CNY 8,960,100.75, significantly down 53.2% from CNY 19,160,727.57 in Q1 2023[22] Other Financial Metrics - The weighted average return on equity was 1.01%, a decrease of 0.01 percentage points compared to the previous year[7] - The company reported a total of CNY 172,851.60 in non-recurring gains and losses for the period[9] - Total operating costs for Q1 2024 were CNY 543,620,372.68, down 1.3% from CNY 551,049,481.13 in Q1 2023[22] - Cash and cash equivalents increased to CNY 756,928,121.90 as of March 31, 2024, up from CNY 715,276,992.64 at the end of 2023, representing a growth of 5.8%[16] - Accounts receivable rose to CNY 398,328,039.01, an increase of 1.5% from CNY 393,179,805.42 at the end of 2023[16] - Inventory decreased to CNY 223,443,090.05, down 7.9% from CNY 242,859,435.85 at the end of 2023[16] - The company experienced a decrease in other comprehensive income, with a net amount of CNY 223,699.68 in Q1 2024, down from CNY 1,987,179.61 in Q1 2023[23] - The total operating cash inflow was CNY 512,993,663.80, while the total operating cash outflow was CNY 470,186,892.47, resulting in a positive net cash flow from operations[24] - The basic and diluted earnings per share remained stable at CNY 0.04 for both Q1 2024 and Q1 2023[23]